1 |
Nasher O, Woodley H, Alizai S, et al. Hepatic benign and malignant masses in children: a single UK tertiary centre experience [J]. Pediatr Sur Int, 2022, 38(12): 2019-2022.
|
2 |
Koh KN, Namgoong JM, Yoon HM, et al. Recent improvement in survival outcomes and reappraisal of prognostic factors in hepatoblastoma [J]. Cancer Med, 2021, 10(10): 3261-3273.
|
3 |
Wu XF, Bai XM, Yang W, et al. Differentiation of atypical hepatic hemangioma from liver metastases: diagnostic performance of a novel type of color contrast enhanced ultrasound [J]. World J Gastroenterol, 2020, 26(9): 960-972.
|
4 |
Wang DC, Jang HJ, Kim TK. Characterization of indeterminate liver lesions on CT and MRI with contrast-enhanced ultrasound: what is the evidence? [J]. AJR Am J Roentgenol, 2020, 214(6): 1295-1304.
|
5 |
Schwarz S, Clevert DA, Ingrisch M, et al. Quantitative analysis of the time–intensity curve of contrast-enhanced ultrasound of the liver: differentiation of benign and malignant liver lesions [J]. Diagnostics (Basel), 2021, 11(7): 1244.
|
6 |
Liu JL, Bao D, Xu ZL, et al. Clinical value of contrast-enhanced computed tomography (CECT) combined with contrast-enhanced ultrasound (CEUS) for characterization and diagnosis of small nodular lesions in liver [J]. Pak J Med Sci, 2021, 37(7): 1843-1848.
|
7 |
Auer TA, Fischer T, Garcia SRM, et al. Value of contrast-enhanced ultrasound (CEUS) in focal liver lesions (FLL) with inconclusive findings on cross-sectional imaging [J]. Clin Hemorheol Microcirc, 2020, 74(3): 327-339.
|
8 |
Hakobyan K, Gaddam M, Ojinnaka U, et al. Contrast-enhanced ultrasound as a main radiological diagnostic method for primary liver neoplasms and hemangiomas [J]. Cureus, 2021, 13(9): e18288.
|
9 |
Höner Zu Siederdissen C, Potthoff A. Sonographische diagnostik bei lebertumoren [J]. Internist (Berl), 2020, 61(2): 115-122.
|
10 |
Jung EM, Weber MA, Wiesinger I. Contrast-enhanced ultrasound perfusion imaging of organs [J]. Radiologe, 2021, 61(Suppl 1): 19-28.
|
11 |
Fang C, Anupindi SA, Back SJ, et al. Contrast-enhanced ultrasound of benign and malignant liver lesions in children [J]. Pediatr Radiol, 2021, 51(12): 2181-2197.
|
12 |
Wang G, Xie X, Chen H, et al. Development of a pediatric liver CEUS criterion to classify benign and malignant liver lesions in pediatric patients: a pilot study [J]. Eur Radiol, 2021, 31(9): 6747-6757.
|
13 |
Knieling F, Strobel D, Rompel O, et al. Spectrum, applicability and diagnostic capacity of contrast-enhanced ultrasound in pediatric patients and young adults after intravenous application - a retrospective trial [J]. Ultraschall Med, 2016, 37(6): 619.
|
14 |
Fang C, Bernardo S, Sellars ME, et al. Contrast-enhanced ultrasound in the diagnosis of pediatric focal nodular hyperplasia and hepatic adenoma: interobserver reliability [J]. Pediatr Radiol, 2019, 49(1): 82-90.
|
15 |
Burrowes DP, Medellin A, Harris AC, et al. Characterization of focal liver masses: a multicenter comparison of contrast‐enhanced ultrasound, computed tomography, and magnetic resonance imaging [J]. J Ultrasound Med, 2021, 40(12): 2581-2593.
|
16 |
Wilson SR, Lyshchik A, Piscaglia F, et al. CEUS LI-RADS: algorithm, implementation, and key differences from CT/MRI [J]. Abdom Radiol (NY), 2018, 43(1): 127-142.
|
17 |
Rafailidis V, Andronikou S, Mentzel HJ, et al. Contrast-enhanced ultrasound of pediatric lungs [J]. Pediatr Radiol, 2021, 51(12): 2340-2350.
|
18 |
Jung EM, Dong Y, Jung F. Current aspects of multimodal ultrasound liver diagnostics using contrast-enhanced ultrasonography (CEUS), fat evaluation, fibrosis assessment, and perfusion analysis-An update [J]. Clin Hemorheol Microcirc, 2023, 83(2): 181-193.
|
19 |
Dietrich CF, Tana C, Caraiani C, et al. Contrast enhanced ultrasound (CEUS) imaging of solid benign focal liver lesions [J]. Expert Rev Gastroenterol Hepatol, 2018, 12(5): 479-489.
|
20 |
Dietrich CF, Augustiniene R, Batko T, et al. European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB): An update on the pediatric CEUS registry on behalf of the "EFSUMB pediatric CEUS registry working group" [J]. Ultraschall Med, 2021, 42(3): 270-277.
|
21 |
Pepin EW, Nordeck SM, Fetzer DT. Nontraditional uses of US contrast agents in abdominal imaging and intervention [J]. Radioimagedatas, 2022, 42(6): 1724-1741.
|
22 |
Dietrich CF, Nolsøe CP, Barr RG, et al. Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) in the liver-update 2020 WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS [J]. Ultrasound Med Biol, 2020, 46(10): 2579-2604.
|
23 |
Fang JQ, Ji YY, Zhao WA, et al. Three cases of hepatic epithelioid hemangioendothelioma evaluated using conventional and contrast‐enhanced ultrasound: Case reports [J]. J Clin Ultrasound, 2022, 50(6): 826-831.
|
24 |
El-Ali AM, McCormick A, Thakrar D, et al. Contrast-enhanced ultrasound of congenital and infantile hemangiomas: preliminary results from a case series [J]. AJR Am J Roentgenol, 2020, 214(3): 658-664.
|
25 |
Klinger C, Stuckmann G, Dietrich CF, et al. Contrast-enhanced imaging in hepatic epithelioid hemangioendothelioma: retrospective study of 10 patients [J]. Z Gastroenterol, 2019, 57(6): 753-766.
|
26 |
Fan PL, Xia HS, Ding H, et al. Characterization of early hepatocellular carcinoma and high‐grade dysplastic nodules on contrast‐enhanced ultrasound [J]. J Ultrasound Med, 2020, 39(9): 1799-1808.
|